Domains A and B in the Rb Pocket Interact To Form a Transcriptional Repressor Motif

REFERENCES

• Adnane, J., Z. Shao, and P. D. Robbins. 1995. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270:8837–8843.
   PubMed Web of Science ®Google Scholar
• Bagchi, S., P. Raychaudhuri, and J. R. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62:659–669.
   PubMed Web of Science ®Google Scholar
• Bandara, L. R., and T. N. La. 1991. Adenovirus E1a prevents the retino-blastoma gene product from complexing with a cellular transcription factor. Nature (London) 351:494–497.
   PubMed Web of Science ®Google Scholar
• Barberis, A., C. W. Muller, S. C. Harrison, and M. Ptashne. 1993. Delineation of two functional regions of transcription factor TFIIB. Proc. Natl. Acad. Sci. USA 90:5628–5632.
   PubMedGoogle Scholar
• Bremner, R., B. L. Cohen, M. Sopta, P. A. Hamel, C. J. Ingles, B. L. Gallie, and R. A. Phillips. 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15:3256–3265.
   PubMedGoogle Scholar
• Chellappan, S., V. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549–4553.
   PubMed Web of Science ®Google Scholar
• Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061.
   PubMed Web of Science ®Google Scholar
• Chen, P. L., P. Scully, J. Y. Shew, J. Y. Wang, and W. H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193–1198.
   PubMed Web of Science ®Google Scholar
• Chow, K. N. B., P. Starostik, and D. C. Dean. The Rb family contains a conserved cdk-regulated transcriptional repressor motif. Submitted for publication.
   Google Scholar
• Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392–2404.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, W. H. Piwnica, C. M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., B. Faha, E. Harlow, and D. M. Livingston. 1992. Interaction of p107 with cyclin A independent of complex formation with viral oncopro-teins. Science 255:85–87.
   PubMed Web of Science ®Google Scholar
• Fisher, R. P., P. Jin, H. M. Chamberlin, and D. O. Morgan. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83:47–57.
   PubMedGoogle Scholar
• Friend, S. H., R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (London) 323:643–646.
   PubMed Web of Science ®Google Scholar
• Fung, Y. K., A. L. Murphree, A. T’Ang, J. Qian, S. H. Hinrichs, and W. F. Benedict. 1987. Structural evidence for the authenticity of the human reti-noblastoma gene. Science 236:1657–1661.
   PubMed Web of Science ®Google Scholar
• Goodrich, D. W., and W. H. Lee. 1993. Molecular characterization of the retinoblastoma susceptibility gene. Biochim. Biophys. Acta 1155:43–61.
   PubMed Web of Science ®Google Scholar
• Hagemeier, C., A. J. Bannister, A. Cook, and T. Kouzarides. 1993. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 90:1580–1584.
   PubMed Web of Science ®Google Scholar
• Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Transcrip-tional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431–3438.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378–2391.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13:3384–3391.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hisatake, K., R. G. Roeder, and M. Horikoshi. 1993. Functional dissection of TFIIB domains required for TFIIB-TFIID-promoter complex formation and basal transcription activity. Nature (London) 363:744–747.
   PubMedGoogle Scholar
• Hu, Q. J., N. Dyson, and E. Harlow. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9:1147–1155.
   PubMed Web of Science ®Google Scholar
• Huang, P. S., D. R. Patrick, G. Edwards, P. J. Goodhart, H. E. Huber, L. Miles, V. M. Garsky, A. Oliff, and D. C. Heimbrook. 1993. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol. Cell. Biol. 13:953–960.
   PubMedGoogle Scholar
• Huang, S., N. P. Wang, B. Y. Tseng, W. H. Lee, and E. H. Lee. 1990. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J. 9:1815–1822.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr., M. E. Ewen, and D. M. Livingston. 1990. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol. 10:3761–3769.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521–532.
   PubMed Web of Science ®Google Scholar
• Kaye, F. J., R. A. Kratzke, J. L. Gerster, and J. M. Horowitz. 1990. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl. Acad. Sci. USA 87:6922–6926.
   PubMed Web of Science ®Google Scholar
• Krek, W., G. F. Xu, and D. M. Livingston. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83:1149–1158.
   PubMed Web of Science ®Google Scholar
• Lanfrancone, L., G. Pelicci, and P. Pelicci. 1994. Cancer genetics. Curr. Opin. Genet. Dev. 4:109–119.
   PubMed Web of Science ®Google Scholar
• La Thangue, N. B. 1994. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:108–114.
   PubMed Web of Science ®Google Scholar
• Lee, W. H., R. Bookstein, F. Hong, L. J. Young, J. Y. Shew, and E. Y. Lee. 1987. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235:1394–1399.
   PubMed Web of Science ®Google Scholar
• Li, Y., C. Graham, S. Lacy, A. M. Duncan, and P. Whyte. 1993. The adeno-virus E1A-associated 130-kD protein is encoded by a member of the reti-noblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366–2377.
   PubMed Web of Science ®Google Scholar
• Ludlow, J. W., J. Shon, J. M. Pipas, D. M. Livingston, and J. A. DeCaprio. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387–396.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1991. Tumor suppressor genes. Cell 64:313–326.
   PubMed Web of Science ®Google Scholar
• Martin, K. J., J. W. Lillie, and M. R. Green. 1990. Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets. Nature (London) 346:147–152.
   PubMedGoogle Scholar
• Mayol, X., X. Grana, A. Baldi, N. Sang, Q. Hu, and A. Giordano. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:2561–2566.
   PubMed Web of Science ®Google Scholar
• Mihara, K., X. R. Cao, A. Yen, S. Chandler, B. Driscoll, A. L. Murphree, A. T’Ang, and Y. K. Fung. 1989. Cell cycle-dependent regulation of phosphor-ylation of the human retinoblastoma gene product. Science 246:1300–1303.
   PubMed Web of Science ®Google Scholar
• Morris, G. F., and M. B. Mathews. 1991. The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site. J. Virol. 65:6397–6406.
   PubMedGoogle Scholar
• Murray, A. 1994. Cell cycle checkpoints. Curr. Opin. Cell Biol. 6:872–876.
   PubMed Web of Science ®Google Scholar
• Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429.
   PubMed Web of Science ®Google Scholar
• Ouellette, M. M., J. Chen, W. E. Wright, and J. W. Shay. 1992. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site. Oncogene 7:1075–1081.
   PubMedGoogle Scholar
• Qian, Y., C. Luckey, L. Horton, M. Esser, and D. J. Templeton. 1992. Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol. Cell. Biol. 12:5363–5372.
   PubMed Web of Science ®Google Scholar
• Qin, X.-Q., T. Chittenden, D. M. Livingston, W. G. Kaelin, Jr. 1992. Identification of a growth suppression domain in the retinoblastoma gene product. Genes Dev. 6:953–964.
   PubMed Web of Science ®Google Scholar
• Qin, X.-Q., D. M. Livingston, M. Ewen, W. R. Sellers, Z. Arany, and W. G. Kaelin, Jr. 1995. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15:742–755.
   PubMedGoogle Scholar
• Sadowski, I., B. Bell, P. Broad, and M. Hollis. 1992. GAL4 fusion vectors for expression in yeast or mammalian cells. Gene 118:137–141.
   PubMed Web of Science ®Google Scholar
• Sellers, W. R., J. W. Rodgers, and W. G. Kaelin. 1995. A potent transre-pression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92:11544–11548.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., K. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature (London) 375:812–815.
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., and D. C. Dean. 1992. Interaction of a common factor with ATF, Sp1, or TATAA promoter elements is required for these sequences to mediate transactivation by the adenoviral oncogene E1a. Mol. Cell. Biol. 12:512–517.
   PubMedGoogle Scholar
• Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (London) 358:259–261.
   PubMed Web of Science ®Google Scholar
• Zawel, L., and D. Reinberg. 1993. Initiation of transcription by RNA poly-merase II: a multi-step process. Prog. Nucleic Acid Res. Mol. Biol. 44:66–108.
   Google Scholar
• Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111–1125.
   PubMed Web of Science ®Google Scholar